Axorus
Develops a non-invasive photoacoustic contact lens for people with retinal blindness, including dry AMD and retinitis pigmentosa
Highlights
- New on EvolcAdded 2026-11-05
About Axorus
Axorus is developing a photoacoustic contact lens and laser glasses that use ultrasound to stimulate retinal neurons. The device is designed as a non-invasive, removable alternative to implants and is in preclinical development.
The product targets patients with retinal blindness, primarily dry age-related macular degeneration and retinitis pigmentosa. Axorus collaborates with Boston University and conducts preclinical trials at the Institut de la Vision in Paris.
Founded in 2019, Axorus is headquartered in Loos, France, and has a Paris office. Since May 2025, it has focused exclusively on developing the contact lens technology.
Product: A photoacoustic contact lens and laser glasses system designed to stimulate retinal neurons non-invasively.
Jobs at Axorus
More health & medtech companies
Azergo
Ergonomic workplace equipment and personalised workstation adaptations for employers and workersNew on EvolcAzmed
AI software for medical imaging that helps healthcare teams detect and triage findings in X-rays and CT scansNew on EvolcAzur Sante Plus
Home care and household services for seniors, people with disabilities and families in the Alpes-MaritimesNew on EvolcAzuradiologie
Radiology group in Nice, France, offering X-ray, ultrasound, CT, MRI and mammography across several imaging centresNew on EvolcAzurvet
Veterinary referral center and diagnostic laboratory serving pet owners, veterinarians and animal clinicsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.